Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization

Cancer Genetics and Cytogenetics

Volumn 177, Issue 1, 2007, Pages 20-29

  Scaruffi, Paola ^a   Coco, Simona ^a   Cifuentes, Francisco ^b   Albino, Domenico ^a   Nair, Manoj ^b   Defferrari, Raffaella ^a   Mazzocco, Katia ^a   Tonini, Gian Paolo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b AGILENT TECHNOLOGIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MYOSTATIN;

AMPLICON; ARTICLE; CHILDHOOD CANCER; CHROMOSOME 10; CHROMOSOME 11Q; CHROMOSOME 13; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 17Q; CHROMOSOME 18; CHROMOSOME 1P; CHROMOSOME 20; CHROMOSOME 2P; CHROMOSOME 3; CHROMOSOME 3P; CHROMOSOME 4; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HUMAN; HUMAN CELL; HUMAN GENOME; NEUROBLASTOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

BLOTTING, SOUTHERN; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN; DNA, NEOPLASM; GENES, MYC; GENOME, HUMAN; HUMANS; KARYOTYPING; NEUROBLASTOMA; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PILOT PROJECTS; PROGNOSIS;

EID: 34547682280     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.05.002     Document Type: Article

References (43)

1. Brodeur G. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3 (2003) 203-216
2. Maris J.M. The biologic basis for neuroblastoma heterogeneity and risk stratification. Curr Opin Pediatr 17 (2005) 7-13
3. Westermann F., and Schwab M. Genetic parameters of neuroblastomas. Cancer Lett 184 (2002) 127-147
4. Kallioniemi A., Kallioniemi O.P., Sudar D., Rutovitz D., Gray J.W., Waldman F., and Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258 (1992) 818-821
5. Brinkschmidt C., Christiansen H., Terpe H., Simon R., Boecker W., Lampert F., and Stoerkel S. Comparative genomic hybridization (CGH) analysis of neuroblastomas-an important methodological approach in paediatric tumour pathology. J Pathol 181 (1997) 394-400
6. Plantaz D., Mohapatra G., Matthay K.K., Pellarin M., Seeger R.C., and Feuerstein B.G. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol 150 (1997) 81-89
7. Vandesompele J., Van Roy N., Van Gele M., Laureys G., Ambros P., Heimann P., Devalck C., Schuuring E., Brock P., Otten J., Gyselinck J., De Paepe A., and Speleman F. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer 23 (1998) 141-152
8. Cunsolo C.L., Bicocchi M.P., Petti A.R., and Tonini G.P. Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status. Br J Cancer 83 (2000) 1295-1300
9. Pinkel D., Segraves R., Sudar D., Clark S., Poole I., Kowbel D., Collins C., Kuo W.L., Chen C., Zhai Y., Dairkee S.H., Ljung B.M., Gray J.W., and Albertson D.G. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20 (1998) 207-211
10. Pollack J.R., Perou C.M., Alizadeh A.A., Eisen M.B., Pergamenschikov A., Williams C.F., Jeffrey S.S., Botstein D., and Brown P.O. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23 (1999) 41-46
11. Snijders A.M., Nowak N., Segraves R., Blackwood S., Brown N., Conroy J., Hamilton G., Hindle A.K., Huey B., Kimura K., Law S., Myambo K., Palmer J., Ylstra B., Yue J.P., Gray J.W., Jain A.N., Pinkel D., and Albertson D.G. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 29 (2001) 263-264
12. Chen Q.R., Bilke S., Wei J.S., Whiteford C.C., Cenacchi N., Krasnoselsky A.L., Greer B.T., Son C.G., Westermann F., Berthold F., Schwab M., Catchpoole D., and Khan J. cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma. BMC Genomics 5 (2004) 70
13. Bilke S., Chen Q., Whiteford C., and Khan J. Detection of low level genomic alterations by comparative genomic hybridization based on cDNA micro-arrays. Bioinformatics 21 (2005) 1138-1145
14. Pinkel D., and Albertson D.G. Comparative genomic hybridization. Annu Rev Genomics Hum Genet 6 (2005) 331-354
15. Redon R., Baujat G., Sanlaville D., Le Merrer M., Vekemans M., Munnich A., Carter N.P., Cormier-Daire V., and Colleaux L. Interstitial 9q22.3 microdeletion: clinical and molecular characterisation of a newly recognised overgrowth syndrome. Eur J Hum Genet 14 (2006) 759-767
16. Beheshti B., Braude I., Marrano P., Thorner P., Zielenska M., and Squire J. Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization. Neoplasia 5 (2003) 53-62
17. De Preter K., Pattyn F., Berx G., Strumane K., Menten B., Van Roy F., De Paepe A., Speleman F., and Vandesompele J. Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA amplicons. BMC Genomics 5 (2004) 11
18. Scaruffi P., Parodi S., Mazzocco K., Defferrari R., Fontana V., Bonassi S., and Tonini G.P. Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization. Mol Diagn 8 (2004) 93-100
19. Mosse Y.P., Greshock J., Margolin A., Naylor T., Cole K., Khazi D., Hii G., Winter C., Shahzad S., Asziz M.U., Biegel J.A., Weber B.L., and Maris J.M. High-resolution detection and mapping of genomic DNA alterations in neuroblastoma. Genes Chromosomes Cancer 43 (2005) 390-403
20. Bignell G., Huang J., Greshock J., Watt S., Butler A., West S., Grigorova M., Jones K., Wei W., Stratton M., Futreal P., Weber B., Shapero M., and Wooster R. High-resolution analysis of DNA copy number using oligonucleotide microarrays. Genome Res 14 (2004) 287-295
21. Brennan C., Zhang Y., Leo C., Feng B., Cauwels C., Aguirre A., Kim M., Protopopov A., and Chin L. High-resolution global profiling of genomic alterations with long oligonucleotide microarray. Cancer Res 64 (2004) 4744-4748
22. Carvalho B., Ouwerkerk E., Meijer G., and Ylstra B. High resolution microarray comparative genomic hybridisation analysis using spotted oligonucleotides. J Clin Pathol 57 (2004) 644-646
23. Scaruffi P., Moretti S., Coco S., Mazzocco K., Defferrari R., Albino D., Bonassi S., and Tonini G. Oligonucleotide array comparative genomic hybridization profiling of neuroblastoma tumours. Cancer Genomics & Proteomics 3 (2006) 245-252
24. Stallings R.L., Nair P., Maris J.M., Catchpoole D., McDermott M., O'Meara A., and Breatnach F. High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma. Cancer Res 66 (2006) 3673-3680
25. Spitz R., Oberthuer A., Zapatka M., Brors B., Hero B., Ernestus K., Oestreich J., Fischer M., Simon T., and Berthold F. Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome. Genes Chromosomes Cancer 45 (2006) 1130-1142
26. Shimada H., Umehara S., Monobe Y., Hachitanda Y., Nakagawa A., Goto S., Gerbing R.B., Stram D.O., Lukens J.N., and Matthay K.K. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer 92 (2001) 2451-2461
27. Sambrook J., Fritsch E., and Maniatis T. Molecular Cloning: A Laboratory Manual (1989), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
28. Coco S., Defferrari R., Scaruffi P., Cavazzana A., Di Cristofano C., Longo L., Mazzocco K., Perri P., Gambini C., Moretti S., Bonassi S., and Tonini G. Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells. J Pathol 207 (2005) 346-357
29. Giordani L., Iolascon A., Servedio V., Mazzocco K., Longo L., and Tonini G. Two regions of deletion in 9p22∼p24 in neuroblastoma are frequently observed in favorable tumors. Cancer Genet Cytogenet 135 (2002) 42-47
30. Tonini G.P., Verdona G., De Bernardi B., Sansone R., Massimo L., and Cornaglia-Ferraris P. N-myc oncogene amplification in a patient with IV-S neuroblastoma. Am J Pediatr Hematol Oncol 9 (1987) 8-10
31. Weber A., Imisch P., Bergmann E., and Christiansen H. Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma. J Clin Oncol 22 (2004) 2681-2690
32. Oberthuer A., Skowron M., Spitz R., Kahlert Y., Westermann F., Mehler K., Berthold F., and Fischer M. Characterization of a complex genomic alteration on chromosome 2p that leads to four alternatively spliced fusion transcripts in the neuroblastoma cell lines IMR-5, IMR-5/75 and IMR-32. Gene 363 (2005) 41-50
33. Yang Q., Zage P., Kagan D., Tian Y., Seshadri R., Salwen H.R., Liu S., Chlenski A., and Cohn S.L. Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma. Clin Cancer Res 10 (2004) 8493-8500
34. Banelli B., Gelvi I., Di Vinci A., Scaruffi P., Casciano I., Allemanni G., Bonassi S., Tonini G., and Romani M. Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors. Oncogene 24 (2005) 5619-5628
35. Selzer R.R., Richmond T.A., Pofahl N.J., Green R.D., Eis P.S., Nair P., Brothman A.R., and Stallings R.L. Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH. Genes Chromosomes Cancer 44 (2005) 305-319
36. Bown N., Lastowska M., Cotterill S., O'Neill S., Ellershaw C., Roberts P., Lewis I., and Pearson A. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K.Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group. Med Pediatr Oncol 36 (2001) 14-19
37. Lastowska M., Cotterill S., Bown N., Cullinane C., Variend S., Lunec J., Strachan T., Pearson A., and Jackson M. Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors. Genes Chromosomes Cancer 34 (2002) 428-436
38. Billin A., Eilers A., Queva C., and Ayer D. Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors. J Biol Chem 274 (1999) 36344-36350
39. Fredman D., White S.J., Potter S., Eichler E.E., and Den Dunnen J.T. Brookes AJ Complex SNP-related sequence variation in segmental genome duplications. Nat Genet 36 (2004) 861-866
40. Sebat J., Lakshmi B., Troge J., Alexander J., Young J., Lundin P., Maner S., Massa H., Walker M., Chi M., Navin N., Lucito R., Healy J., Hicks J., Ye K., Reiner A., Gilliam T.C., Trask B., Patterson N., Zetterberg A., and Wigler M. Large-scale copy number polymorphism in the human genome. Science 305 (2004) 525-528
41. Iafrate A., Feuk L., Rivera M., Listewnik M., Donahoe P., Qi Y., Scherer S., and Lee C. Detection of large-scale variation in the human genome. Nat Genet 36 (2004) 949-951
42. Hyman E., Kauraniemi P., Hautaniemi S., Wolf M., Mousses S., Rozenblum E., Ringner M., Sauter G., Monni O., Elkahloun A., Kallioniemi O., and Kallioniemi A. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62 (2002) 6240-6245
43. Pollack J.R., Sorlie T., Perou C.M., Rees C.A., Jeffrey S.S., Lonning P.E., Tibshirani R., Botstein D., Borresen-Dale A.L., and Brown P.O. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A 99 (2002) 12963-12968